Rojiani honored with 2024 College of American Pathologists Lifetime Achievement Award
Dr. Amyn Rojiani, chair of the Department of Pathology and Laboratory Medicine and professor at Penn State College of Medicine and Penn State Health Milton S. Hershey Medical Center, received the 2024 College of American Pathologists (CAP) Lifetime Achievement Award.
The award recognizes his academic leadership in pathology, particularly inpatient care, education and research.
“Dr. Rojiani has demonstrated a lifelong passion for teaching, mentoring and leading the next generation of pathologists, demonstrated through his efforts in program development, teaching, faculty development, mentorship and his promotion of diversity, equity and inclusion, including religious and cultural minorities, in the field,” CAP noted.
Rojiani has worked internationally in East Africa and Asia as a visiting professor teaching in pathology residency programs in 2010, 2011 and 2014. He received the Teaching Excellence Award in 2008 for teaching in the Osler Board Review Course. He is a frequently invited lecturer on topics exploring medical management, medical education, diversity and cultural issues, gender in medicine and society, and opportunities for increasing parity and progress.
Rojiani has previously served as vice president of the American Association of Neuropathologists. He serves on the American Association of Physician Leadership’s Council of Fellows, which recently recognized him as a Distinguished Fellow – the only pathologist to ever receive this honor. He also chairs the Association for Academic Pathology’s (formerly the Association of Pathology Chairs’) Leadership Development Committee. He has chaired the Georgia delegation to the CAP House of Delegates for six years and served on multiple national CAP committees.
In addition to multiple editorial boards and grant review sections, Rojiani is widely published, with more than 150 peer-reviewed publications, invited reviews and book chapters to his name. He tallies more than 6,958 citations and an h-index of 43.
His research interests include demyelination, Alzheimer’s disease, vascular targeting agents, neuro-oncology and, more recently, matrix interactions in lung cancer.
If you're having trouble accessing this content, or would like it in another format, please email the Penn State College of Medicine web department.